Cargando…

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease

Background: The use of antiplatelet agents in ischemic moyamoya disease (MMD) is controversial. This study aimed to investigate the effectiveness and safety of antiplatelet therapy compared with conservative treatment and surgical revascularization in ischemic MMD patients. Methods: Ischemic MMD pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Fei, Li, Jiaoxing, Wang, Tianzhu, Lan, Kai, Li, Haiyan, Yin, Haoyuan, Guo, Tongli, Zhang, Xiong, Yang, Tingting, Liang, Jie, Wu, Xiaoxin, Li, Qi, Sheng, Wenli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844095/ https://www.ncbi.nlm.nih.gov/pubmed/33519687 http://dx.doi.org/10.3389/fneur.2020.608000

Ejemplares similares

Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China
por: Ye, Fei, et al.
Publicado: (2021)

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

Development and Validation of a Five-Gene Signature to Predict Relapse-Free Survival in Multiple Sclerosis
por: Ye, Fei, et al.
Publicado: (2020)

N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
por: Ye, Fei, et al.
Publicado: (2021)

RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway
por: Ye, Fei, et al.
Publicado: (2023)

Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Hemorrhagic Transformation in Ischemic Moyamoya Disease: Clinical Characteristics, Radiological Features, and Outcomes
por: Lu, Junlin, et al.
Publicado: (2020)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Association Between Ultrasound Parameters and History of Ischemic or Hemorrhagic Stroke in Patients With Moyamoya Disease
por: Zheng, Shuai, et al.
Publicado: (2021)

Safety and efficacy of remote ischemic conditioning in adult moyamoya disease patients undergoing revascularization surgery: a pilot study
por: Yang, Heng, et al.
Publicado: (2023)

TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease
por: Chen, Yuanbing, et al.
Publicado: (2022)

APOE as potential biomarkers of moyamoya disease
por: Wu, Haibin, et al.
Publicado: (2023)

Incidental Moyamoya Disease in an Elderly Patient Presenting With Acute Ischemic Pontine Stroke
por: Abou-El-Hassan, Hadi, et al.
Publicado: (2023)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Moyamoya Disease With Initial Ischemic or Hemorrhagic Attack Shows Different Brain Structural and Functional Features: A Pilot Study
por: Hu, Junwen, et al.
Publicado: (2022)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

AND score: a simple tool for predicting infection in acute ischemic stroke patients without a ventilator in the Chinese population
por: Li, Jiaoxing, et al.
Publicado: (2019)

Evaluation of Revascularization in Different Suzuki Stages of Ischemic Moyamoya Disease by Whole-Brain CT Perfusion
por: Han, Qingdong, et al.
Publicado: (2021)

Moyamoya: An Update and Review
por: Berry, James A, et al.
Publicado: (2020)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Comparison of Long-Term Effect Between Direct and Indirect Bypass for Pediatric Ischemic-Type Moyamoya Disease: A Propensity Score-Matched Study
por: Zhao, Yahui, et al.
Publicado: (2019)

Application of intraarterial superselective indocyanine green angiography in bypass surgery for adult moyamoya disease
por: Ni, Haojin, et al.
Publicado: (2023)

Daily Remote Ischemic Conditioning Can Improve Cerebral Perfusion and Slow Arterial Progression of Adult Moyamoya Disease—A Randomized Controlled Study
por: Xu, Jiali, et al.
Publicado: (2022)

Epidemiology of Moyamoya Angiopathy in Eastern India
por: Das, Shambaditya, et al.
Publicado: (2022)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Effect of cerebral oxygen saturation monitoring in patients undergoing superficial temporal anterior-middle cerebral artery anastomosis for ischemic Moyamoya disease: a prospective cohort study
por: Chen, Xuanling, et al.
Publicado: (2023)

Recognition of the Effect of Indirect Revascularization for Moyamoya Disease: The Balance Between the Stage Progression and Neoangiogenesis
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

The -7351C/T Polymorphism in the TPA Gene and Ischemic Stroke Risk: A Meta-Analysis
por: Sun, Xunsha, et al.
Publicado: (2013)

A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How
por: Si, Xiaoli, et al.
Publicado: (2020)

Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
por: Zanaty, Mario, et al.
Publicado: (2020)

Clinical value of the systemic immune-inflammation index in moyamoya disease
por: Liu, Erheng, et al.
Publicado: (2023)

Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment
por: Lu, Liang, et al.
Publicado: (2023)

Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Moyamoya Disease: A Review of Current Literature
por: Gupta, Apurv, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ccmc9qmb3d1d72fk9he1sq43fc